EAGLE GLOBAL ADVISORS LLC

Position in NVS — Novartis AG

CIK 1130787 Houston, TX

Position in NVS

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$218,624

+$5,538 QoQ

Shares Held

1,395

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,277

of 1,603 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 57% Shared 0% None 43%

Healthcare · as of Jun 30, 2026

EAGLE GLOBAL ADVISORS LLC holds $90,990,326 across 10 Drug Manufacturers - General names. NVS ranks #10 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	89,170	$22,646,504
2	LLY	ELI LILLY & Co	17,945	$21,523,773
3	ABBV	AbbVie Inc.	79,227	$19,936,682
4	MRK	Merck & Co., Inc.	138,101	$17,745,978
5	AZN	Astrazeneca PLC	37,609	$7,131,418
6	AMGN	Amgen Inc	1,640	$593,876
7	BIIB	Biogen Inc.	2,609	$563,700
8	PFE	Pfizer Inc	13,800	$332,304

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$218,624	1,395	0.0%	Shares	Sole	2026-07-30
2026-03-31	$213,086	1,395	-58.2%	Shares	Sole	2026-05-15
2023-03-31	$307,280	3,340	-88.0%	Shares	Sole	2023-05-08
2022-12-31	$2,517,752	27,753	-1.7%	Shares	Sole	2023-02-07
2022-09-30	$2,145,762	28,230	-2.9%	Shares	Sole	2022-10-25
2022-06-30	$2,458,808	29,088	-4.0%	Shares	Sole	2022-08-11
2022-03-31	$2,659,088	30,303	+0.5%	Shares	Sole	2022-04-20
2021-12-31	$2,638,182	30,161	-3.7%	Shares	Sole	2022-02-01
2021-09-30	$2,560,450	31,309	-0.7%	Shares	Sole	2021-11-15
2021-06-30	$2,876,249	31,524	+2.4%	Shares	Sole	2021-07-15
2021-03-31	$2,632,698	30,799	-2.6%	Shares	Sole	2021-05-07
2020-12-31	$2,984,743	31,608	-2.7%	Shares	Sole	2021-02-01
2020-09-30	$2,826,026	32,498	-0.4%	Shares	Sole	2020-10-22
2020-06-30	$2,850,166	32,633	-3.2%	Shares	Sole	2020-08-14
2020-03-31	$2,778,812	33,703	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.